Women in the UK who took the pregnancy drug Diethylstilbestrol - also known as DES or Stilbestrol - could be screened by the NHS after studies uncovered a 30% higher risk of breast cancer ...

Stilbestrol, also known as DES, was prescribed on the NHS to prevent miscarriage and to stop breast milk production from 1939 until the late 1970s. | ITV National News ...

Many FDA accelerated approvals continue to rely heavily on surrogate endpoints, raising ongoing uncertainty about the true clinical benefits of these therapies.

The U.S. Food and Drug Administration (FDA) recently announced a new Commissioner’s National Priority Voucher (CNPV) program, ...

Ovarian Cancer Drugs Market grows as FDA, EMA fast-track advanced-stage therapies, boosting global approvals and innovation. Anurag Tiwari Orion Market Research Pvt Ltd + +91 91798 28694 email us here ...

Our large observational study adds long-term survival to the mounting data supporting the use and safety of conservative surgery for low-risk, early-stage cervical carcinoma,” the researchers wrote.

The FDA has approved a groundbreaking new therapy for patients battling late-stage melanoma, offering hope when options run out.

Cervical cancer, the second most prevalent cancer among women worldwide, is primarily attributed to the human papillomavirus (HPV). Despite advances in healthcare, it remains a significant cause of ...

Determined to make HPV and cervical cancer screenings less invasive, these researchers have turned to menstrual blood.

Nephrotoxicity: Cisplatin, the main chemo drug used to treat cervical cancer, can damage the kidneys (also called nephrotoxicity). Many times the damage is preventable and reversible, but sometimes it ...

Electra D. Paskett, PhD, MSPH, FACE, FAACR, was elected as a fellow to the American Association for Cancer Research Academy ...

Finding cervical cancer often starts with an abnormal HPV (human papillomavirus) or Pap test result. This will lead to further tests which can diagnose cervical cancer or pre-cancer. The Pap test and ...